
|Articles|April 29, 2013
Essilor, HPO enter exclusive global license agreement
Advertisement
Charenton le Pont, France-Essilor has signed an exclusive and global license agreement with High Performance Optics (HPO), that complements its existing patent and technologies portfolio. This license agreement will allow Essilor to continue to focus on products with correction and preventive benefits and to roll out its portfolio of products around the world.
The pact enables Essilor to strengthen its mission of reaching the 4.2 billion people worldwide who need vision correction.
As a result of the company’s R&D and innovation processes, Essilor currently has approximately 5,600 patents throughout the world that help extend its strategy.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Remote Area Medical: Lindsay Elkins, OD, FAAO, on care for underserved communities
2
WaveDȳn integrates with Bausch + Lomb and WAVE for scleral lens fitting
3
What Lytenava FDA approval means for compounded bevacizumab in AMD
4
Study finds that current ophthalmic patient letters may pose comprehension difficulty
5






















